Proceedings: The effects of glucagon on the hepatic arterial vasculature of the dog: an inhibition of the effects of vasoconstrictor agents.
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001158:Arteries / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D005260:Female; D005934:Glucagon / Q000494:pharmacology*; D008099:Liver / Q000098:blood supply*; D009638:Norepinephrine / Q000494:pharmacology; D014662:Vasoconstrictor Agents / Q000037:antagonists & inhibitors*; D014667:Vasopressins / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D014662:Vasoconstrictor Agents; D014667:Vasopressins; D000804:Angiotensin II; D005934:Glucagon; D009638:Norepinephrine